Postoperative Radiotherapy for the Treatment of Solitary Fibrous Tumor With Malignant Transformation of the Pelvic: A Rare Case Report With Literature Review

Medicine
Chao GaoYong-Hua Yu

Abstract

Solitary fibrous tumor of the pelvic is an uncommon neoplasm with nonspecific symptoms. Reports of malignant transformation are especially rare. We report a case of solitary fibrous tumor in pelvic. A unique feature of our case compared with previously reported is that this patient relapsed with malignant transformation and had significant response to radiotherapy. The patient was initially treated with surgery, followed by postoperative dimensional conformal intensity modulated radiation therapy (dynamic MLC VRIAN 23EX Linac, inversely optimized by the Eclipse system) to provide a radical cure for residual tumor.In this case, there were no signs of recurrence after six and a half years of further follow-up, indicating that postoperation radiotherapy may be an effective treatment for SFT with malignant transformation in pelvic.

References

Jan 1, 1992·American Journal of Industrial Medicine·P Klemperer, B R Coleman
Aug 1, 1989·The American Journal of Surgical Pathology·D M EnglandM J McCarthy
Sep 1, 1987·International Journal of Radiation Oncology, Biology, Physics·N JhaJ Kong
Aug 1, 1985·Cancer·J E Tepper, H D Suit
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J C YangS A Rosenberg
Jan 11, 2000·AJR. American Journal of Roentgenology·M TruongB L Kemp
Feb 24, 2001·Deutsche medizinische Wochenschrift·C G DietrichS Matern
May 1, 1960·Radiology·M FRIEDMAN, J W EGAN
Mar 27, 2004·Archives of Pathology & Laboratory Medicine·Rani Kanthan, Bahman Torkian
Mar 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Matthew T BalloPeter W T Pisters
Nov 3, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S R GrobmyerS Singer
Aug 19, 2005·The New England Journal of Medicine·Matthew A ClarkJ Meirion Thomas
Oct 11, 2005·Journal of Magnetic Resonance Imaging : JMRI·Arastoo VossoughMarc P Banner
Nov 1, 2006·Cancer Control : Journal of the Moffitt Cancer Center·Lary A Robinson
Feb 24, 2007·Pathology International·Shinobu KawamuraJunya Fukuoka
May 12, 2007·Pathology, Research and Practice·Pavol ZuborJan Danko
Feb 14, 2009·Cancer Genetics and Cytogenetics·Francisco J Torres-OliveraRicardo González-Cámpora
Apr 8, 2009·Applied Immunohistochemistry & Molecular Morphology : AIMM·Yingchuan HuHaodong Xu
May 12, 2010·Molecular Cancer Therapeutics·Silvia StacchiottiSilvana Pilotti
Oct 5, 2011·Surgery Today·Hidetoshi KatsunoRyouta Hanaoka
Apr 10, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S StacchiottiP G Casali
Jul 28, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·S StacchiottiP G Casali
Nov 19, 2013·World Neurosurgery·Angelina Graziella MeloneAntonio Santoro

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.